The store will not work correctly when cookies are disabled.
ethyl 4-((4-aminophenyl)ethynyl)-6-methoxyquinoline-2-carboxylate
ID: ALA4637708
PubChem CID: 156011178
Max Phase: Preclinical
Molecular Formula: C21H18N2O3
Molecular Weight: 346.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc(C#Cc2ccc(N)cc2)c2cc(OC)ccc2n1
Standard InChI: InChI=1S/C21H18N2O3/c1-3-26-21(24)20-12-15(7-4-14-5-8-16(22)9-6-14)18-13-17(25-2)10-11-19(18)23-20/h5-6,8-13H,3,22H2,1-2H3
Standard InChI Key: RAWAYYZHLDKMKN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
39.2609 -22.8648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2598 -23.6843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9678 -24.0933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9660 -22.4559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6746 -22.8612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6754 -23.6802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3839 -24.0873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0922 -23.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0875 -22.8543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3784 -22.4510 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.7927 -22.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5029 -22.8457 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.7877 -21.6243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.2081 -22.4328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9182 -22.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5517 -24.0924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.8443 -23.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3856 -24.9045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3796 -25.7209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3736 -26.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6594 -26.9376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6531 -27.7540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3583 -28.1687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0714 -27.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0742 -26.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3533 -28.9859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
2 16 1 0
16 17 1 0
7 18 1 0
18 19 3 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.39 | Molecular Weight (Monoisotopic): 346.1317 | AlogP: 3.40 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.44 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.92 | CX LogP: 3.81 | CX LogD: 3.81 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.45 | Np Likeness Score: -0.77 |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |